Elaia announces final close of DTS3 at €134M
Elaia has closed its third deep tech seed fund (DTS3) at €134 million, double the size of its previous deep tech seed funds. Developed in partnership with leading European research institutions including PSL, INRIA, CNRS, the Barcelona Supercomputing Center, and also the Max Planck Foundation, DTS3 reflects strong investor confidence in Europe's growing deep tech ecosystem.
Since its first close of €60 million in March 2024, DTS3 has already deployed capital across 11 portfolio companies in computing, life sciences, and industrial innovation. DTS3 will invest from €1M to €13M in pre-seed and seed-stage B2B startups across Europe, partnering with founders at the earliest stages.
Partnership with Europe's leading research institutions
"DTS3 builds on a partnership model we pioneered through the PSL Innovation Fund and Elaia Alpha II Fund, which has already produced notable outcomes including Aqemia, Alice&Bob, and Mablink Bioscience, acquired by Eli Lilly," said Anne-Sophie Carrese, Partner at Elaia.